The Inbound Health shutdown on December 1, 2025, ended operations at a Minneapolis-based healthcare technology startup that had publicly announced $50 million in funding. The company, which helped hospitals deliver advanced medical care in patients’ homes, closed after failing to raise additional capital.
Inbound Health confirmed the closure and employee layoffs as uncertainty over federal support for hospital-at-home services disrupted its business outlook. The company did not disclose how many employees lost their jobs.
Axios Pro first reported the shutdown, citing an audio recording about the company’s closure. Inbound Health subsequently confirmed the development to healthcare industry publications.
Inbound Health Shutdown Follows Funding Difficulties
Inbound Health said it couldn’t secure the additional investment needed to maintain normal operations.
The company attributed much of the difficulty to uncertainty around Medicare’s Acute Hospital Care at Home initiative, which lets approved hospitals provide inpatient-level services in qualifying patients’ homes.
The federal program had been disrupted during the government shutdown in the fall of 2025. Its reliance on temporary congressional extensions also made long-term business planning difficult.
In a statement reported by Home Health Care News, Inbound Health said the lack of a lasting extension had prevented it from obtaining additional financing.
The company confirmed it had laid off employees and was exploring strategic alternatives. It also said it was working with customers on transition arrangements.
The company did not disclose its remaining cash balance, the size of its funding shortfall or a final employee count.
Inside the Closure of the Hospital-at-Home Startup
The closure became public on December 1, when Axios Pro reported that Inbound Health had stopped operating.
The announcement followed years of effort to build technology and operational services for health systems that wanted to provide more treatment at home.
Inbound Health was not a traditional home healthcare agency. Its business was designed to help hospitals and health plans establish and manage advanced home-based care programs.
Those services included clinical operations, remote patient monitoring, staffing coordination, logistics and technology used to organize treatment outside hospital facilities.
The company also supported programs that let certain patients recover at home rather than remain in a skilled nursing facility.
Its closure affected the business that provided those services, although the company did not publish a complete account of how individual hospital partnerships were transferred or concluded.
Inbound Health Raised $50 Million Before Closing.
Inbound Health became independent in 2022 after developing within Minneapolis-based Allina Health.
The startup launched with approximately $20 million in financing from investors including Flare Capital Partners.
In September 2023, it secured another $30 million through a Series B round led by HealthQuest Capital, with participation from Flare Capital Partners and McKesson Ventures.
The investment brought its publicly announced financing to $50 million.
According to a Home Health CareNews funding report, the company intended to use the money to enter additional markets, develop new care programs, and expand the infrastructure supporting home-based healthcare.
Chief executive Dave Kerwar had presented Inbound Health as a partner for hospitals looking to expand services beyond their buildings.
The financing supported those ambitions, but the company ultimately needed additional investment to continue.
The amount raised should not be confused with its valuation or the amount investors lost. The closure announcement did not establish either figure.
Hospital Partnerships Expanded Before the Shutdown
Inbound Health had established relationships with healthcare providers in several U.S. markets.
In April 2024, SSM Health announced a partnership to deliver post-hospital recovery services to eligible patients in Wisconsin.
The SSM Health program combined in-person visits with remote monitoring and virtual consultations.
The organizations subsequently expanded their collaboration to hospital-level care at home.
In June 2025, Valley Health System in New Jersey announced plans to launch a hospital-at-home program with Inbound Health.
The Valley Health partnership announcement described services for eligible patients with conditions such as pneumonia, heart failure and cellulitis.
Patients would receive clinical assessments, monitoring, and visits from healthcare professionals while staying at home.
These partnerships demonstrated that Inbound Health had customers and an established operating model. They did not guarantee that the company would secure enough financing to sustain the business.
Why Medicare Rules Created Uncertainty
The federal Acute Hospital Care at Home initiative began in November 2020 during the COVID-19 pandemic.
The program allows approved hospitals to provide hospital-level treatment in patients’ homes while meeting specific requirements for clinical care, safety and monitoring.
It opened opportunities for healthcare systems to develop alternatives to conventional inpatient treatment.
However, hospitals and technology providers needed confidence that Medicare would continue supporting the model.
Congress repeatedly extended the initiative for relatively short periods. When authorization temporarily lapsed during the 2025 government shutdown, some participating hospitals had to suspend services or return patients to hospital settings.
Inbound Health told industry reporters that this uncertainty undermined its ability to attract further investment.
The company did not say that demand for home-based care had disappeared. Its explanation centered on regulatory instability and the resulting financing difficulties.
Congress Later Extended the Program Through 2030
The federal policy landscape changed after Inbound Health closed.
In February 2026, Congress approved legislation extending the Acute Hospital Care at Home initiative through September 30, 2030.
The extension gave hospitals participating in the program a longer planning horizon.
According to the Centers for Medicare & Medicaid Services, eligible hospitals can continue seeking authorization to deliver inpatient-level services at home under the initiative’s requirements.
The extension addressed a major concern that had affected the industry in 2025.
However, it came too late to prevent Inbound Health’s December closure.
The later legislation also should not be interpreted as evidence that the startup would have survived had the extension been approved earlier. Its complete financial circumstances were not publicly disclosed.
MedArrive Acquired Inbound Health Technology in March 2026
Although Inbound Health ceased operations, a new owner acquired some of its technology.
On March 18, 2026, healthcare technology company MedArrive announced that it had acquired assets from the former startup.
The transaction included AI-supported patient-navigation capabilities designed to help healthcare providers identify patients who might be ready to move from hospital treatment to home-based care.
The software uses clinical and operational information to support care decisions and coordinate transfers.
MedArrive planned to combine the acquired capabilities with its existing platform for scheduling clinicians, managing home visits and coordinating care teams.
As Healthcare Dive reported, the acquisition also brought customer relationships that could support MedArrive’s expansion.
The companies did not publicly disclose the purchase price.
The transaction involved acquiring selected assets, not confirming that Inbound Health had resumed operations.
It also did not say how many former employees, if any, MedArrive subsequently hired.
How Many Employees Lost Their Jobs?
Inbound Health confirmed that it laid off employees when it shut down.
However, the company did not publish an official number of affected workers.
That means the closure can be included in technology and healthcare startup layoff coverage, but it should not be assigned a precise employee figure without additional evidence.
TechAmerica.ai documents other closures and workforce reductions in its 2025 technology layoffs report.
Unlike a company reducing one department while continuing to operate, Inbound Health ended its business as an independent operating startup.
The subsequent sale of selected technology assets did not change that outcome.
What Inbound Health’s Closure Means for Digital Healthcare
Inbound Health’s closure illustrates a financial challenge facing healthcare technology businesses that depend on regulated reimbursement models.
A company may have promising technology, established partnerships and significant investor backing yet still struggle if customers and financiers cannot predict the rules governing its services.
In this case, Inbound Health directly linked its inability to secure additional funding to uncertainty over Medicare’s hospital-at-home program.
The 2026 extension through September 2030 has since given the wider sector greater regulatory stability.
Meanwhile, MedArrive’s acquisition shows that parts of Inbound Health’s technology remained commercially useful after the startup closed.
TechAmerica.ai continues to cover related developments in its Biotech & Health section, including digital health technology, medical devices and healthcare innovation.
For Inbound Health, the outcome was a business closure following $50 million in announced funding, employee layoffs without a disclosed headcount and a later sale of selected technology assets.
The case illustrates how some healthcare technology startups depend on both private financing and stable public healthcare policy.










